Published On: Wed, Sep 14th, 2016

Endo International PLC (ENDP) Short Interest Update

Endo International PLC (NASDAQ:ENDP) saw a significant growth in short interest in August. As of August 31st, there was short interest totalling 13,712,139 shares, a growth of 14.6% from the August 15th total of 11,962,171 shares. Approximately 6.9% of the company’s shares are short sold. Based on an average trading volume of 6,198,653 shares, the short-interest ratio is presently 2.2 days.
A number of large investors have recently made changes to their positions in ENDP. Norges Bank acquired a new stake in shares of Endo International PLC during the fourth quarter valued at about $97,137,000. Heartland Advisors Inc. acquired a new stake in shares of Endo International PLC during the second quarter valued at about $15,627,000. State Street Corp raised its stake in shares of Endo International PLC by 9.3% in the second quarter. State Street Corp now owns 9,430,866 shares of the company’s stock valued at $147,021,000 after buying an additional 805,101 shares during the period. Schneider Capital Management Corp acquired a new stake in shares of Endo International PLC during the second quarter valued at about $6,941,000. Finally, Quantitative Investment Management LLC raised its stake in shares of Endo International PLC by 166.2% in the second quarter. Quantitative Investment Management LLC now owns 654,800 shares of the company’s stock valued at $10,208,000 after buying an additional 408,800 shares during the period. 96.66% of the stock is currently owned by hedge funds and other institutional investors.
Endo International PLC (NASDAQ:ENDP) opened at 20.34 on Wednesday. The firm’s market cap is $4.53 billion. The firm’s 50-day moving average is $20.55 and its 200 day moving average is $22.83. Endo International PLC has a 1-year low of $12.56 and a 1-year high of $84.57.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/09/14/endo-international-plc-endp-short-interest-update.html

Endo International PLC (NASDAQ:ENDP) last announced its quarterly earnings results on Monday, August 8th. The company reported $0.86 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.74 by $0.12. The firm had revenue of $921 million for the quarter, compared to analyst estimates of $873.50 million. Endo International PLC had a negative net margin of 25.90% and a positive return on equity of 15.54%. The business’s revenue for the quarter was up 25.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.08 EPS. On average, equities analysts forecast that Endo International PLC will post $4.56 earnings per share for the current fiscal year.
A number of equities research analysts recently weighed in on the stock. Deutsche Bank AG reaffirmed a “buy” rating and set a $31.00 price target on shares of Endo International PLC in a report on Wednesday, June 15th. JMP Securities reaffirmed a “buy” rating on shares of Endo International PLC in a report on Wednesday, June 29th. Stifel Nicolaus lowered their price target on shares of Endo International PLC from $75.00 to $25.00 and set a “buy” rating for the company in a report on Wednesday, May 18th. Vetr lowered shares of Endo International PLC from a “strong-buy” rating to a “buy” rating and set a $19.14 price target for the company. in a report on Thursday, July 7th. Finally, JPMorgan Chase & Co. set a $40.00 price target on shares of Endo International PLC and gave the company a “buy” rating in a report on Tuesday, August 9th. One equities research analyst has rated the stock with a sell rating, eleven have given a hold rating and eleven have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $40.00.
About Endo International PLC
Endo International PLC, formerly Endo Health Solutions Inc is a specialty healthcare solutions company focused on branded and generic pharmaceuticals, devices and services. The Company has a portfolio of branded pharmaceuticals that includes brands, such as Lidoderm, Opana ER, Voltaren Gel, Percocet, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel.

Receive News & Ratings for Endo International PLC Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Endo International PLC and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>